Revvity | PKI - 市值



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 12.47B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


市值 更改 日
Agilent USD 32.66B 5.2B 2026-03
Align Technology USD 12.28B 1.07B 2026-03
Bio Techne USD 8.18B 987M 2026-03
Bruker USD 5.5B 1.66B 2026-03
Charles River Laboratories USD 7.85B 2.17B 2026-03
Danaher USD 128.46B 33.24B 2026-03
Dentsply International USD 2.32B 36M 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.78B 215M 2025-12
Divis Laboratories Ltd INR 1.58T 118.27B 2026-03
Edwards Lifesciences USD 46.17B 3.3B 2026-03
Illumina USD 17.88B 2.74B 2026-03
Intuitive Surgical USD 163.73B 37.04B 2026-03
IQVIA Holdings USD 28.63B 9.76B 2026-03
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Laboratory Of America USD 21.93B 1.13B 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Mettler Toledo International USD 25.54B 2.94B 2026-03
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
OraSure Technologies USD 174M 61M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pacific Biosciences Of California USD 565M 180M 2025-12
Pharma Mar EUR 1.57B 225M 2026-03
Qiagen NV USD 8.27B 1.62B 2026-03
Quest Diagnostics USD 21.69B 2.39B 2026-03
Quidel USD 1.01B 984M 2026-03
Repligen USD 6.64B 2.58B 2026-03
Revvity USD 9.94B 1.03B 2026-03
Sartorius EUR 14.25B 2.16B 2026-03
Thermo Fisher Scientific USD 182.66B 35.04B 2026-03
Waters USD 29.87B 7.25B 2026-03
Zealand Pharma A/S 33.35B 448.34M 2025-12